ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy-Reference-Cited by-同舟云学术

ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy

Published:2022-07 Issue:7 Volume:63 Page:100237
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Deng Mingjuan,Kutrolli Elda,Sadewasser Anne^ORCID,Michel Sven^ORCID,Joibari Masoumeh Motamedi,Jaschinski Frank,Olivecrona Gunilla,Nilsson Stefan K.,Kersten Sander^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference59 articles.

1. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society;Ginsberg;Eur. Heart J.,2021

2. Physiological regulation of lipoprotein lipase;Kersten;Biochim. Biophys. Acta,2014

3. Regulation of lipoprotein lipase-mediated lipolysis of triglycerides;Basu;Curr. Opin. Lipidol.,2020

4. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk;Kersten;Curr. Opin. Lipidol.,2019

5. Atypical angiopoietin-like protein that regulates ANGPTL3;Quagliarini;Proc. Natl. Acad. Sci. U. S. A.,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New approaches to triglyceride reduction: Is there any hope left?;American Journal of Preventive Cardiology;2024-06

2. Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk;European Heart Journal Open;2024-04-30

3. Characterization of sexual dimorphism in ANGPTL4 levels and function;Journal of Lipid Research;2024-04

4. The association between plasma angiopoietin-like protein 4, glucose and lipid metabolism during pregnancy, placental function, and risk of delivering large-for-gestational-age neonates;Clinica Chimica Acta;2024-02

5. Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk;2024-01-23